Inventor · disambiguated record
Hui Li
Also filed as: LI HUI · LI HUI-YIN · LI HUI-YIN H
244 granted patents·68 pending applications·5,246 citations·filing 1994–2025
99Inventor score
Files withRIGEL PHARMACEUTICALS INC107SINGH RAJINDER17LI HUI15HARDIE JAMES TECHNOLOGY LTD12INCYTE CORP12
Top patents by PatentIndex Score
312 records- 0199US8853397B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Oct 7, 2014·45 cites·7 claims
- 0299US8835430B22,4-pyrimidinediamine compounds and their usesSINGH RAJINDER·Filed 2013·Granted Sep 16, 2014·48 cites·16 claims
- 0399US8829013B1Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrileINCYTE CORP·Filed 2014·Granted Sep 9, 2014·91 cites·14 claims
- 0499US8822685B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Sep 2, 2014·43 cites·17 claims
- 0599US8822481B1Salts of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrileINCYTE CORP·Filed 2014·Granted Sep 2, 2014·89 cites·28 claims
- 0699US8722693B2Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrileINCYTE CORP·Filed 2013·Granted May 13, 2014·143 cites·10 claims
- 0799US7820819B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Oct 26, 2010·87 cites·17 claims
- 0899US7655797B2Intermediates for making 2,4-pyrimidinediamine compoundsRIGEL PHARMACEUTICALS INC·Filed 2008·Granted Feb 2, 2010·81 cites·21 claims
- 0999US7642351B22,4-Pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Jan 5, 2010·105 cites·14 claims
- 1099US7589200B25-Fluoro-4N-phenyl-4-pyrimidineamine compoundsRIGEL PHARMACEUTICALS INC·Filed 2004·Granted Sep 15, 2009·102 cites·18 claims
- 1199US7582648B2Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compoundsRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Sep 1, 2009·114 cites·3 claims
- 1299US7557210B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2003·Granted Jul 7, 2009·190 cites·16 claims
- 1399US7550460B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2007·Granted Jun 23, 2009·95 cites·18 claims
- 1499US7498435B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Mar 3, 2009·93 cites·21 claims
- 1599US7485724B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Feb 3, 2009·119 cites·20 claims
- 1699US7452879B2Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compoundsRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Nov 18, 2008·110 cites·13 claims
- 1799US7435814B22,4-Pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2005·Granted Oct 14, 2008·94 cites·11 claims
- 1899US7332484B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2005·Granted Feb 19, 2008·146 cites·4 claims
- 1999US7329672B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2005·Granted Feb 12, 2008·130 cites·19 claims
- 2099US7329671B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2005·Granted Feb 12, 2008·147 cites·19 claims
- 2199US7122542B2Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compoundsRIGEL PHARMACEUTICALS INC·Filed 2004·Granted Oct 17, 2006·218 cites·6 claims
- 2299US7060827B2Intermediates useful for making 2,4-pyrimidinediamine compoundsRIGEL PHARMACEUTICALS INC·Filed 2004·Granted Jun 13, 2006·255 cites·11 claims
- 2398US11213528B2Salts of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrileINCYTE HOLDINGS CORP·Filed 2020·Granted Jan 4, 2022·5 cites·16 claims
- 2498US9464088B2Piperidin-4-yl azetidine derivatives as JAK1 inhibitorsINCYTE CORP·Filed 2014·Granted Oct 11, 2016·57 cites·49 claims
- 2598US9376439B2Salts of the janus kinase inhibitor (R)-3(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrileINCYTE CORP·Filed 2014·Granted Jun 28, 2016·62 cites·26 claims
- 2698US8188276B22,4-pyrimidinediamine compounds and their usesSINGH RAJINDER·Filed 2009·Granted May 29, 2012·50 cites·11 claims
- 2798US8148525B22,4-pyrimidinediamine compounds and their usesSINGH RAJINDER·Filed 2010·Granted Apr 3, 2012·69 cites·12 claims
- 2898US7906644B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Mar 15, 2011·46 cites·1 claims
- 2998US7825116B2N2, N4-bis-aryl-5-fluoro-2,4-pyrimidinediaminesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Nov 2, 2010·55 cites·8 claims
- 3098US7812029B1Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compoundsRIGEL PHARMACEUTICALS INC·Filed 2008·Granted Oct 12, 2010·73 cites·23 claims
- 3198US7560466B2Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compoundsRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Jul 14, 2009·56 cites·11 claims
- 3298US7517886B2Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compoundsRIGEL PHARMACEUTICALS INC·Filed 2003·Granted Apr 14, 2009·141 cites·28 claims
- 3398US7491732B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Feb 17, 2009·105 cites·6 claims
- 3497US12031012B2Antidegradant composition, antidegradant master batch and rubber compositionSENNICS CO LTD·Filed 2021·Granted Jul 9, 2024·2 cites·20 claims
- 3597US10696672B2Amino acid compounds and methods of usePLIANT THERAPEUTICS INC·Filed 2017·Granted Jun 30, 2020·21 cites·34 claims
- 3697US10610530B2Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrileINCYTE HOLDINGS CORP·Filed 2018·Granted Apr 7, 2020·8 cites·28 claims
- 3797US10125150B2Crystalline forms of a PI3K inhibitorINCYTE CORP·Filed 2018·Granted Nov 13, 2018·15 cites·31 claims
- 3897US9988401B2Crystalline forms of a PI3K inhibitorINCYTE CORP·Filed 2016·Granted Jun 5, 2018·14 cites·27 claims
- 3997US8765734B2Piperidin-4-yl azetidine derivatives as JAK1 inhibitorsHUANG TAISHENG·Filed 2011·Granted Jul 1, 2014·116 cites·12 claims
- 4097US8410266B22,4-pyrimidinediamine compounds and their usesSINGH RAJINDER·Filed 2011·Granted Apr 2, 2013·30 cites·13 claims
- 4197US8334296B22,4-pyrimidinediamine compounds and their usesSINGH RAJINDER·Filed 2008·Granted Dec 18, 2012·39 cites·5 claims
- 4297US8158621B2Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compoundsSINGH RAJINDER·Filed 2010·Granted Apr 17, 2012·48 cites·14 claims
- 4397US7884111B22,4-pyrimidinediamine compounds and uses as anti-proliferative agentsRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Feb 8, 2011·75 cites·12 claims
- 4497US7858633B2Cycloalkyl substituted pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Dec 28, 2010·66 cites·5 claims
- 4597US7834024B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2008·Granted Nov 16, 2010·59 cites·6 claims
- 4697US7803939B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2008·Granted Sep 28, 2010·77 cites·21 claims
- 4796US11634418B2Amino acid compounds and methods of usePLIANT THERAPEUTICS INC·Filed 2020·Granted Apr 25, 2023·5 cites·41 claims
- 4896US10793564B2Amino acid compounds and methods of usePLIANT THERAPEUTICS INC·Filed 2019·Granted Oct 6, 2020·25 cites·69 claims
- 4996US10259826B2Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compoundsRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Apr 16, 2019·6 cites·7 claims
- 5096US9913842B22,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2016·Granted Mar 13, 2018·8 cites·28 claims
Showing the top 50 of 312 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Hui Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →